Angelo Agathanggelou

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

Michal Zimmermann, Olga Murina, Martin A.M. Reijns et al. · Nature · 2018 · 418 citations · Full text

Life Sciences, Genetics, Molecular Biology +10

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

Angelo Agathanggelou, Sofia Honorio, Donia Macartney‐Coxson et al. · Oncogene · 2001 · 379 citations

Medicine, Genetics, Oncology +14

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

Oliver Goodyear, Angelo Agathanggelou, Igor Novitzky‐Basso et al. · Blood · 2010 · 339 citations · Full text

Medicine, Oncology, Pharmacology +17

ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells

Marwan Kwok, Nicholas Davies, Angelo Agathanggelou et al. · Blood · 2015 · 276 citations

Life Sciences, Cancer Biology, Oncology +16

EPSTEIN-BARR VIRUS (EBV) INFECTION IN INFECTIOUS MONONUCLEOSIS: VIRUS LATENCY, REPLICATION AND PHENOTYPE OF EBV-INFECTED CELLS

Gerald Niedobitek, Angelo Agathanggelou, Hermann Herbst et al. · The Journal of Pathology · 1997 · 217 citations

Life Sciences, Microbiology, Pathology +14